Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients. (Q53639918)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Multivariable risk of developing new onset diabetes after transplant-results from a single-center study of 481 adult, primary kidney transplant recipients. (English)

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

author name string

Jeffrey J Gaynor

1

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Gaetano Ciancio

2

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Giselle Guerra

3

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Junichiro Sageshima

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Lois Hanson

5

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

David Roth

6

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Michael J Goldstein

7

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Linda Chen

8

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Warren Kupin

9

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Adela Mattiazzi

10

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Lissett Tueros

11

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Sandra Flores

12

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Luis J Barba

13

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Adrian Lopez

14

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Jose Rivas

15

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Phillip Ruiz

16

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Rodrigo Vianna

17

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

George W Burke

18

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

publication date

18 February 2015

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Clinical Transplantation

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

29

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

301-310

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

4

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

Risk for posttransplant Diabetes mellitus with current immunosuppressive medications

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Patient survival after renal transplantation: IV. Impact of post-transplant diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Posttransplantation diabetes: a systematic review of the literature

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Diabetes mellitus after kidney transplantation in the United States

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Incidence and Cost of New Onset Diabetes Mellitus Among U.S. Wait-Listed and Transplanted Renal Allograft Recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

New onset hyperglycemia and diabetes are associated with increased cardiovascular risk after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Reduced incidence of new-onset posttransplantation diabetes mellitus during the last decade

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Impact of acute rejection and new-onset diabetes on long-term transplant graft and patient survival

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Association of metabolic syndrome with development of new-onset diabetes after transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

The association of early post-transplant glucose levels with long-term mortality.

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Diabetes and kidney transplantation: past, present, and future

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Posttransplantation diabetes mellitus in FK-506-treated renal transplant recipients: analysis of incidence and risk factors

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

New-onset diabetes mellitus in transplant patients: pathogenesis, complications, and management

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

New-onset diabetes after kidney transplantation-changes and challenges

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Reduced exposure to calcineurin inhibitors in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

A randomized long-term trial of tacrolimus and sirolimus versus tacrolimus and mycophenolate mofetil versus cyclosporine (NEORAL) and sirolimus in renal transplantation. I. Drug interactions and rejection at one year

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

A randomized long-term trial of tacrolimus/sirolimus versus tacrolimus/mycophenolate mofetil versus cyclosporine (NEORAL)/sirolimus in renal transplantation. II. Survival, function, and protocol compliance at 1 year

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Randomized trial of immunosuppressive regimens in renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

A randomized trial of three renal transplant induction antibodies: early comparison of tacrolimus, mycophenolate mofetil, and steroid dosing, and newer immune-monitoring

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

A randomized trial of thymoglobulin vs. alemtuzumab (with lower dose maintenance immunosuppression) vs. daclizumab in renal transplantation at 24 months of follow-up

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Randomized trial of thymoglobulin versus alemtuzumab (with lower dose maintenance immunosuppression) versus daclizumab in living donor renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Favorable outcomes with machine perfusion and longer pump times in kidney transplantation: a single-center, observational study.

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Diagnosis and classification of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Cyclosporine and sirolimus pharmacokinetics and drug-to-drug interactions in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Pretransplant risk score for new-onset diabetes after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FCTR.12510

21 January 2018

Identifiers

10.1111/CTR.12510

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

1 reference

Europe PubMed Central

16 May 2018

http://europepmc.org/abstract/MED/25581205

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53639918&oldid=876037454"